Filing Details

Accession Number:
0000899243-21-002905
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-01-22 16:05:09
Reporting Period:
2021-01-20
Accepted Time:
2021-01-22 16:05:09
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1797336 Ayala Pharmaceuticals Inc. AYLA () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1647053 Roni Mamluk Oppenheimer 4
Rehovot L3 7670104
President & Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-01-20 19,466 $15.03 179,877 No 4 S Direct
Common Stock Disposition 2021-01-21 1,406 $15.04 178,471 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan.